Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
22.2M
-
Shares change
-
-3.64M
-
Total reported value, excl. options
-
$136M
-
Value change
-
-$20.8M
-
Put/Call ratio
-
4.42
-
Number of buys
-
37
-
Number of sells
-
-46
-
Price
-
$6.15
Significant Holders of Arrowhead Pharma Inc - COM (ARWR) as of Q4 2015
120 filings reported holding ARWR - Arrowhead Pharma Inc - COM as of Q4 2015.
Arrowhead Pharma Inc - COM (ARWR) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.2M shares
.
Largest 10 shareholders include OppenheimerFunds, Inc. (3M shares), VANGUARD GROUP INC (2.29M shares), BlackRock Fund Advisors (2.28M shares), QVT Financial LP (1.95M shares), JPMORGAN CHASE & CO (1.59M shares), BlackRock Institutional Trust Company, N.A. (1.54M shares), BAKER BROS. ADVISORS LP (1.01M shares), STATE STREET CORP (942K shares), AMERIPRISE FINANCIAL INC (920K shares), and NORTHERN TRUST CORP (632K shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.